[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597202":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":10,"responsibleParty":18,"collaborators":10,"id":22,"slug":23,"hasResults":24,"nctId":25,"briefTitle":26,"officialTitle":27,"acronym":10,"eligibilityCriteria":28,"healthyVolunteers":24,"sex":29,"minAge":30,"maxAge":10,"enrollmentInfo":31,"targetDuration":10,"studyType":34,"phases":10,"briefSummary":35,"conditions":36,"keywords":42,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":10},{"fullName":5,"class":6},"Marmara University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Men Over 40 With LUTS",null,"Male patients aged 40 years or older presenting with lower urinary tract symptoms (LUTS), who undergo uroflowmetry and renal function testing, and complete the IPSS questionnaire. No interventions will be applied. This group will be prospectively observed for the association between Qmax\u002FeGFR ratio and symptom severity.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"günal özgür, Urology Specialist","CONTACT","+905357849485","gunalozgur91@hotmail.com",{"type":19,"investigatorFullName":20,"investigatorTitle":21,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Tarik Emre Sener","Assoc. Prof.","100597202","association-between-qmaxegfr-ratio-and-luts-severity-in-men-over-40-100597202",false,"NCT07055425","Association Between Qmax\u002FeGFR Ratio and LUTS Severity in Men Over 40","The Role of Qmax\u002FeGFR Ratio in Assessing Symptom Severity and QoL in Men Over 40 With LUTS","Inclusion Criteria:\n\n* Male patients aged 40 years or older presenting with lower urinary tract symptoms (LUTS)\n* Able to provide informed consent\n* Willing and able to undergo uroflowmetry and blood testing\n* Able to complete the IPSS questionnaire, including the QoL item\n* Estimated glomerular filtration rate (eGFR) ≥ 30 mL\u002Fmin\u002F1.73m²\n\nExclusion Criteria:\n\n* History of urological surgery (e.g., prostatectomy, bladder surgery)\n* Diagnosed or suspected prostate cancer\n* Active urinary tract infection (based on clinical symptoms or urinalysis)\n* Neurological conditions affecting bladder function (e.g., Parkinson's disease, spinal cord injury)\n* Presence of an indwelling urinary catheter at enrollment\n* eGFR \\\u003C 30 mL\u002Fmin\u002F1.73m²\n* Inability to perform uroflowmetry or complete clinical evaluations","MALE","40 Years",{"count":32,"type":33},100,"ESTIMATED","OBSERVATIONAL","This study will look at how well a measure called the Qmax\u002FeGFR ratio is related to the severity of urination problems in men over the age of 40. Qmax is a test that shows how fast a person can urinate, and eGFR is a number that reflects kidney function. Men who have urinary symptoms will be asked to do a urine flow test, a blood test, and fill out a questionnaire about their symptoms and quality of life. We will study if there is a link between the Qmax\u002FeGFR ratio and how severe their symptoms are. The results may help doctors better understand how kidney and urinary function are related in men with these problems.",[37,38,39,40,41],"Lower Urinary Tract Symptom","Voiding Dysfunction","Male Urological Health","Renal Function","Benign Prostate Obstruction (BPO)",[37,41,39,38,43],"Aging Male","NOT_YET_RECRUITING","2025-08-30",{"date":47,"type":48},"2025-09-05","ACTUAL",{"date":50,"type":33},"2025-09-01",{"date":52,"type":33},"2026-05-01",{"name":5,"class":6}]